Trump’s Bold Plan: Linking U.S. Drug Prices to International Rates for Affordable Healthcare

Former President Trump plans to sign an executive order aimed at reducing drug prices in the United States. This strategy would tie U.S. prices to those in other wealthy nations. Trump shared this update on Truth Social, highlighting the need to ensure Americans pay the lowest possible prices.

He describes the plan as a "most favored nation" model. However, specifics are still unclear—especially regarding which drugs and insurance types would be affected. Trump’s assertion is that this approach could lead to unprecedented reductions in healthcare costs.

Historically, Trump attempted a similar initiative during his first term focusing on Medicare, a program that supports over 68 million seniors and disabled individuals. That effort aimed at a selective group of 50 drugs used in hospitals but faced legal obstacles when a federal court ruled the administration had not followed proper procedures.

The pharmaceutical industry is strongly opposed to this new proposal, fearing it could cut into profits and reduce investment in research. Critics argue that if companies earn less, patients might miss out on new medicines. A recent survey showed that 70% of Americans support lowering drug prices, reflecting widespread concern over high healthcare costs.

As discussions of this policy heat up in Washington, it’s apparent that any new plan will likely face legal challenges. Nonetheless, the need for solutions in the healthcare sector is pressing, highlighted also by recent studies indicating that nearly 50% of Americans struggle to afford their medications.

For more in-depth information on Medicare and drug pricing, check the Centers for Medicare & Medicaid Services here.

Source link

Drugs (Pharmaceuticals),Prices (Fares, Fees and Rates),Health Insurance and Managed Care,United States Politics and Government,Executive Orders and Memorandums,Trump, Donald J